Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma × Hydroxyurea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Meningioma 7 Brain Neoplasms 6 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Leukemia, Myeloid, Acute 4 Neoplasms 3 Glioblastoma 3 Stomach Neoplasms 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Thyroid Carcinoma, Anaplastic 1 Thrombocytosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pharyngeal Neoplasms 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nose Neoplasms 1 Nasopharyngeal Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1

Interventions

Cisplatin 19 Paclitaxel 15 Carboplatin 15 Gemcitabine 12 pembrolizumab 11 Fluorouracil 8 Specimen Handling 7 Radiotherapy 7 Nivolumab 6 Magnetic Resonance Spectroscopy 6 Docetaxel 6 cemiplimab 5 Sunitinib 5 Platinum 5 Oxaliplatin 5 Everolimus 5 Cyclophosphamide 5 Capecitabine 5 durvalumab 4 anlotinib 4 Radiotherapy, Intensity-Modulated 4 Pemetrexed 4 Drug Therapy 4 Cetuximab 4 1,2-diaminocyclohexaneplatinum II citrate 4 padeliporfin 3 epothilone B 3 atezolizumab 3 Panitumumab 3 Leucovorin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00468169 2019-10-09

EPIC

University of Chicago

Phase 2 Completed

110 enrolled 14 charts

Carcinoma, Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡